| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_645f19583d71fa603d8b057a522734d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a8142c2b92a4b269ce87ca0c7134070 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64150ba414832af841f8042a1f656367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69caf78d313744c1d56c26735e72724f |
| publicationDate |
2014-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014193964-A2 |
| titleOfInvention |
Prognostic and predictive breast cancer signature |
| abstract |
Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involving one or more upstream activators and/or downstream effectors of TET1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9476100-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107630093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434528-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111500717-A |
| priorityDate |
2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |